de Goldman Sachs Ironwood Pharmaceuticals IRWD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 14 M | Comprar |
3,313,808
+623,174
| +23% | +USD 2.4 M | ﹤0.01% | 2970 |
|
|
2026
Q1 | USD 9.44 M | Comprar |
2,690,634
+1,415,319
| +111% | +USD 5.8 M | ﹤0.01% | 3119 |
|
|
2025
Q4 | USD 4.3 M | Comprar |
1,275,315
+190,948
| +18% | +USD 496 k | ﹤0.01% | 3885 |
|
|
2025
Q3 | USD 1.42 M | Vender |
1,084,367
-360,363
| -25% | -USD 373 k | ﹤0.01% | 4770 |
|
|
2025
Q2 | USD 1.04 M | Vender |
1,444,730
-130,686
| -8% | -USD 103 k | ﹤0.01% | 4669 |
|
|
2025
Q1 | USD 2.32 M | Comprar |
1,575,416
+660,144
| +72% | +USD 1.57 M | ﹤0.01% | 4029 |
|
|
2024
Q4 | USD 4.05 M | Vender |
915,272
-307,865
| -25% | -USD 1.25 M | ﹤0.01% | 3660 |
|
|
2024
Q3 | USD 5.04 M | Vender |
1,223,137
-340,295
| -22% | -USD 1.83 M | ﹤0.01% | 3336 |
|
|
2024
Q2 | USD 10.2 M | Comprar |
1,563,432
+183,770
| +13% | +USD 1.3 M | ﹤0.01% | 2484 |
|
|
2024
Q1 | USD 12 M | Comprar |
1,379,662
+297,997
| +28% | +USD 3.62 M | ﹤0.01% | 2311 |
|
|
2023
Q4 | USD 12.4 M | Vender |
1,081,665
-24,904
| -2% | -USD 246 k | ﹤0.01% | 2332 |
|
|
2023
Q3 | USD 10.7 M | Comprar |
1,106,569
+112,105
| +11% | +USD 1.1 M | ﹤0.01% | 2335 |
|
|
2023
Q2 | USD 10.6 M | Vender |
994,464
-82,833
| -8% | -USD 890 k | ﹤0.01% | 2398 |
|
|
2023
Q1 | USD 11.3 M | Comprar |
1,077,297
+59,169
| +6% | +USD 663 k | ﹤0.01% | 2303 |
|
|
2022
Q4 | USD 12.6 M | Vender |
1,018,128
-390,589
| -28% | -USD 4.43 M | ﹤0.01% | 2372 |
|
|
2022
Q3 | USD 14.6 M | Comprar |
1,408,717
+416,590
| +42% | +USD 4.72 M | ﹤0.01% | 2145 |
|
|
2022
Q2 | USD 11.4 M | Vender |
992,127
-1,625,784
| -62% | -USD 19.2 M | ﹤0.01% | 2387 |
|
|
2022
Q1 | USD 32.9 M | Vender |
2,617,911
-693,230
| -21% | -USD 7.95 M | 0.01% | 1649 |
|
|
2021
Q4 | USD 38.6 M | Comprar |
3,311,141
+235,865
| +8% | +USD 2.89 M | 0.01% | 1553 |
|
|
2021
Q3 | USD 40.2 M | Comprar |
3,075,276
+43,705
| +1% | +USD 565 k | 0.01% | 1450 |
|
|
2021
Q2 | USD 39 M | Comprar |
3,031,571
+1,450,335
| +92% | +USD 16.6 M | 0.01% | 1476 |
|
|
2021
Q1 | USD 17.7 M | Vender |
1,581,236
-581,872
| -27% | -USD 6.15 M | ﹤0.01% | 2038 |
|
|
2020
Q4 | USD 24.6 M | Comprar |
2,163,108
+1,055,370
| +95% | +USD 11.5 M | 0.01% | 1682 |
|
|
2020
Q3 | USD 10 M | Vender |
1,107,738
-54,238
| -5% | -USD 539 k | ﹤0.01% | 2327 |
|
|
2020
Q2 | USD 12 M | Comprar |
1,161,976
+388,915
| +50% | +USD 3.98 M | ﹤0.01% | 2127 |
|
|
2020
Q1 | USD 7.8 M | Vender |
773,061
-575,937
| -43% | -USD 6.77 M | ﹤0.01% | 2278 |
|
|
2019
Q4 | USD 18 M | Comprar |
1,348,998
+316,575
| +31% | +USD 3.49 M | ﹤0.01% | 1960 |
|
|
2019
Q3 | USD 8.86 M | Comprar |
1,032,423
+231,208
| +29% | +USD 2.25 M | ﹤0.01% | 2410 |
|
|
2019
Q2 | USD 8.76 M | Vender |
801,215
-1,234,362
| -61% | -USD 13.8 M | ﹤0.01% | 2467 |
|
|
2019
Q1 | USD 23.1 M | Comprar |
2,035,577
+7,672
| +0.4% | +USD 85.7 k | 0.01% | 1750 |
|
|
2018
Q4 | USD 17.6 M | Comprar |
2,027,905
+662,469
| +49% | +USD 7.6 M | 0.01% | 1910 |
|
|
2018
Q3 | USD 21.1 M | Comprar |
1,365,436
+245,150
| +22% | +USD 3.88 M | 0.01% | 1869 |
|
|
2018
Q2 | USD 17.9 M | Comprar |
1,120,286
+143,824
| +15% | +USD 2.13 M | ﹤0.01% | 1960 |
|
|
2018
Q1 | USD 12.6 M | Comprar |
976,462
+439,205
| +82% | +USD 5.47 M | ﹤0.01% | 2165 |
|
|
2017
Q4 | USD 6.74 M | Comprar |
537,257
+323,736
| +152% | +USD 4.23 M | ﹤0.01% | 2755 |
|
|
2017
Q3 | USD 2.82 M | Vender |
213,521
-739,837
| -78% | -USD 10.2 M | ﹤0.01% | 3674 |
|
|
2017
Q2 | USD 15.1 M | Vender |
953,358
-299,744
| -24% | -USD 4.36 M | ﹤0.01% | 2186 |
|
|
2017
Q1 | USD 17.9 M | Vender |
1,253,102
-71,692
| -5% | -USD 980 k | ﹤0.01% | 1965 |
|
|
2016
Q4 | USD 17 M | Vender |
1,324,794
-294,434
| -18% | -USD 3.72 M | ﹤0.01% | 2076 |
|
|
2016
Q3 | USD 21.5 M | Comprar |
1,619,228
+1,179,344
| +268% | +USD 13.8 M | 0.01% | 1830 |
|
|
2016
Q2 | USD 4.82 M | Comprar |
439,884
+212,697
| +94% | +USD 2.08 M | ﹤0.01% | 2902 |
|
|
2016
Q1 | USD 2.08 M | Comprar |
227,187
+92,895
| +69% | +USD 766 k | ﹤0.01% | 3429 |
|
|
2015
Q4 | USD 1.3 M | Vender |
134,292
-67,082
| -33% | -USD 648 k | ﹤0.01% | 4038 |
|
|
2015
Q3 | USD 1.76 M | Vender |
201,374
-491,620
| -71% | -USD 4.59 M | ﹤0.01% | 3927 |
|
|
2015
Q2 | USD 7 M | Comprar |
692,994
+263,033
| +61% | +USD 3.06 M | ﹤0.01% | 2650 |
|
|
2015
Q1 | USD 5.76 M | Vender |
429,961
-473,046
| -52% | -USD 6.21 M | ﹤0.01% | 2763 |
|
|
2014
Q4 | USD 11.6 M | Comprar |
903,007
+442,602
| +96% | +USD 5.07 M | ﹤0.01% | 2234 |
|
|
2014
Q3 | USD 5 M | Vender |
460,405
-256,689
| -36% | -USD 2.94 M | ﹤0.01% | 3020 |
|
|
2014
Q2 | USD 9.21 M | Vender |
717,094
-11,715
| -2% | -USD 127 k | ﹤0.01% | 2433 |
|
|
2014
Q1 | USD 7.52 M | Comprar |
728,809
+564,732
| +344% | +USD 6.35 M | ﹤0.01% | 2616 |
|
|
2013
Q4 | USD 1.6 M | Comprar |
164,077
+99,927
| +156% | +USD 897 k | ﹤0.01% | 4304 |
|
|
2013
Q3 | USD 636 k | Vender |
64,150
-172,929
| -73% | -USD 1.7 M | ﹤0.01% | 4973 |
|
|
2013
Q2 | USD 1.97 M | Comprar |
+237,079
| Nuevas | +USD 2.87 M | ﹤0.01% | 3750 |
|
Otros fondos que tienen IRWD en su cartera
Posición de Goldman Sachs en IRWD: resumen de T2 2026
Goldman Sachs aumentó su participación en Ironwood Pharmaceuticals (IRWD) en 23% durante T2 2026, al comprar aproximadamente USD 2.4 M y elevar la posición a 3,313,808 acciones con un valor de USD 14 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2970.
Goldman Sachs reportó por primera vez una posición en IRWD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 40.2 M en T3 2021. Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank mantienen una posición en IRWD.
- Al cierre de T2 2026, Goldman Sachs tenía 3,313,808 acciones de Ironwood Pharmaceuticals con un valor de USD 14 M.
- Goldman Sachs compró 623,174 acciones de Ironwood Pharmaceuticals en T2 2026, por un monto estimado de USD 2.4 M.
- Ironwood Pharmaceuticals representó ﹤0.01% de la cartera de Goldman Sachs en T2 2026 y fue su posición número 2970.
- Goldman Sachs reportó por primera vez una posición en Ironwood Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Goldman Sachs en Ironwood Pharmaceuticals alcanzó su máximo de USD 40.2 M en T3 2021.
- Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank tenían Ironwood Pharmaceuticals en cartera.
Según el Informe 13F de Goldman Sachs correspondiente a T2 2026, presentado el 14 ago 2026.